| MYQORZO CYTOKINETICS INCORPORATED
2246972 21 Mar 2023 | on 21 Mar 2023 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use, namely medications to treat cardiovascular conditions; pharmaceutical preparations to treat hypertrophic cardiomyopathies, heart failure, and heart failure with preserved ejection fraction | | | MYQORZO LOGO CYTOKINETICS INCORPORATED
2321269 11 Apr 2024 | on 11 Apr 2024 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use, namely, medications to treat cardiovascular conditions; pharmaceutical preparations to treat hypertrophic cardiomyopathies, heart failure, and heart failure with preserved ejection fraction | | 
